This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Andrew Rodriguez, PhD
Director, Process Chemistry at Ionis Pharmaceuticals
Speaker

Profile

Andrew Rodriguez has worked as a Process Chemist at Ionis Pharmaceuticals for the last 14 years, where he strives to optimize the various synthetic and purification processes used in oligonucleotide manufacture and to characterize oligonucleotide impurities. Andrew is a synthetic chemist by training who earned a Ph.D. in Organic Chemistry from UC Irvine and a B.S. in Chemistry from UC Santa Barbara.

Agenda Sessions

  • Characterization and Mitigation of Impurities in Oligonucleotides Containing Methansulfonylphosphoramidate Linkages

    3:00pm